跳至主要内容
临床试验/NCT01034254
NCT01034254已完成3 期

Field Trial of Maternal Influenza Immunization in Asia

Children's Hospital Medical Center, Cincinnati1 个研究点 分布在 1 个国家目标入组 3,693 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
3,693
试验地点
1
主要终点
Field Trial of Maternal Influenza Immunization

研究概览

简要总结

This project is designed to assess the efficacy of immunizing women during pregnancy with influenza vaccine on the health of these women during their pregnancy and for 6 months post-partum as well as on the health of their newborn infants during the first 6 months of life. It will be conducted in Sarlahi District in southern Nepal, a rural area where a number of large scale randomized trials have been conducted over the past 20 years.

详细描述

This is a community-based, placebo-controlled, individually randomized trial in trial among women who are or who become pregnant in 9 Village Development Committees in Sarlahi District, Nepal. The study population for this trial will include all women who are identified as pregnant with gestational age between 17 and 34 weeks gestation during a 12-month period in 9 Village Development Committees (VDC) of Sarlahi District, Nepal. The 9 VDCs include: Dhungre Khola, Karmaiya, Hariaun, Ghurkauli, Sasapur, Netraganj, Lalbandi, Jabdi, and Raniganj.

The vaccine that will be given will be the most current vaccine at the time of subject enrollment. That is, for women enrolled after October in either study cohort, the vaccine will be switched to the newly available vaccine for that year.

The control group will be placebo (saline injection). The justification for the use of a placebo injection in this trial is as follows: There is only one trial (Bangladesh) that demonstrates efficacy of influenza vaccination in pregnancy on perinatal outcomes and respiratory morbidity in early infancy. One of the issues with that study is that it was not placebo controlled. The "control" in that study was adult pneumococcal vaccine. It could be that the Bangladesh study underestimated the impact of influenza vaccine because the mothers and infants receive some indirect protection from the pneumococcal vaccine. In addition, influenza vaccine is not part of national policy or recommendations in Nepal at the current time and Ministry of Health officials are very interested in the results of our study as they consider their immunization program expansion over the next few years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • mid to late pregnancy

排除标准

  • do not intend to deliver in the study area
  • previous pregnancy in this study

结局指标

主要结局

Field Trial of Maternal Influenza Immunization

时间窗: 2 annual recruitment cycles coinciding with flu seasons

To compare, in women randomized to receive either influenza vaccine or control during pregnancy and their infants (through 6 months of age) a) the incidence of influenza-like illness or lab-confirmed influenza episodes b) the distribution of causes of febrile illness and the incidence of clinic visits and hospitalizations c) the incidence of low birth weight, the distribution of birth weight and gestational age and the growth of infants.

次要结局

  • Pertussis In Infants(2 annual rucruiting cycles)
  • Substudy #1: Transplacental Transfer of Influenza Antibody from Mother to Infant(2 annual recruitment cycles)
  • Substudy #3: Hepatitis E Infection in Pregnancy(2 annual recruiting cycles)
  • Substudy #2: Indirect Protection of Maternal Influenza Vaccination on Family Members(2 annual recruiting cycles)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验